Preparing for China · patient guide

Myeloproliferative neoplasm care: the records a specialist needs first

For a myeloproliferative neoplasm review, a specialist first needs the documents that establish the diagnosis and the trend: serial complete blood counts, the bone marrow report, mutation testing, spleen and symptom information, and a dated list of every treatment with its response. A single recent blood test rarely answers the question. Send a short summary first, then the organised files the receiving clinician asks for.

Go to the practical guidance ↓
AI illustration: A female medical professional in a white coat reviewing documents at a desk with folders and a notebook.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

Start with the diagnosis, not the whole archive

Myeloproliferative neoplasms are a group of chronic blood disorders in which the bone marrow overproduces one or more types of blood cells. The World Health Organization classification separates them into entities such as polycythaemia vera, essential thrombocythaemia and primary myelofibrosis, and the diagnostic criteria differ between them. That matters for records: a specialist reviewing your case needs to see which criteria were applied, not only the name on a discharge letter.

The most useful first message is therefore short. State the diagnosis you have been given, when it was made, which clinician or centre made it, your current treatment and your single main question. Examples of a workable question are whether the diagnosis should be reclassified, whether current therapy is still appropriate, or what a change in blood counts might mean. A vague request for a full review gives the clinician less to work with than a specific decision you need help making.

After that summary, the detailed files can follow. The sections below describe what a haematology specialist typically wants to see and why. They are a guide to organising records, not a test list to complete on your own. Any new test should be ordered by a treating clinician who has examined you and knows your history.

Blood counts over time carry more weight than one result

A complete blood count is the backbone of MPN assessment. Haemoglobin, haematocrit, platelet count and white cell count, with the differential, are read together and, crucially, as a trend. A haematocrit that has drifted upward over a year tells a different story from a single value at the top of the reference range. Ask your laboratory or clinic for the full series with dates, not a summary line.

Include counts from before treatment started, during any treatment changes and at the most recent visit. If you have had a thrombotic or bleeding event, note the date and the counts around it. If you have been phlebotomised for polycythaemia vera, record the dates and volumes, because the frequency of venesection is part of how disease control is judged.

Iron studies are often relevant, since iron deficiency can mask or mimic changes in red cell measures. If these have been done, include them. Do not stop or start iron supplements on the basis of an article; that decision belongs to your treating clinician, who can see the whole picture.

Bone marrow and mutation reports need their original detail

The bone marrow biopsy report is often the single most important document for an MPN review. Send the full report, including the morphological description, cellularity, the degree of fibrosis if assessed, and any comment on blast percentage. A one-line conclusion such as "consistent with MPN" is far less useful than the underlying description, because a reviewing haematologist may interpret the same features differently or want to check whether the diagnostic criteria were fully met.

Mutation testing is equally central. JAK2, CALR and MPL results should be sent with the specific variant and, where reported, the allele burden. A negative JAK2 result is not the end of the story, and the combination of findings across these genes influences classification. If your centre performed additional sequencing, include that report too, along with the laboratory's methodology note if available.

Ask whether the original slides or tissue blocks can be requested. A reviewing centre may wish to re-examine the marrow or repeat a test on stored material, and that is a clinical decision for the receiving team. Whether such material can be transferred internationally, and under what conditions, is a practical question to confirm with both the originating laboratory and the receiving hospital before shipping anything.

Spleen, symptoms and vascular history

MPN care is not only about numbers. Spleen size, recorded by imaging or examination, is part of the assessment, particularly where myelofibrosis is suspected or disease is progressing. Send the imaging report with the date and the measured dimensions rather than the image files alone; the radiologist's measurements are what a clinician will compare over time.

Constitutional symptoms matter as well. Fatigue, night sweats, fever, weight loss, early satiety, itching after a warm shower and bone pain are all relevant, and a specialist will want to know when they began and how they have changed. A short dated symptom diary written by you is more useful than a recollection at the appointment.

Vascular history deserves its own line in your summary. Previous thrombosis, bleeding, pregnancy complications, surgery and current antithrombotic or antiplatelet treatment should be listed with dates. These details influence how a haematologist thinks about risk and treatment, and they are easy to omit when a patient focuses only on the blood counts.

A dated treatment history with responses and current medicines

List every MPN-directed treatment in order, with start and stop dates and the reason for each change. Include hydroxycarbamide, interferon preparations, ruxolitinib or other JAK inhibitors, aspirin or anticoagulants, and any clinical trial or investigational agent. For each, note what happened: did the counts respond, were there side effects, was the dose reduced?

Add the current medication list exactly as prescribed, including doses and frequencies, plus allergies and any over-the-counter or herbal products you take. Do not adjust anything before a review. If you are unsure whether a product interacts with your treatment, ask your prescribing clinician or pharmacist rather than relying on general advice.

Recent imaging, liver and kidney function, and any bone density or vaccination records may be requested depending on the treatment you have received. Send what exists and note what is missing. A reviewing clinician can work with an incomplete file by telling you what would change the assessment; they cannot work with a file that silently omits a treatment year.

How to send records and what to confirm before travelling

Begin with a brief summary through the enquiry route, then share records only through the channel the team confirms. Do not send passport numbers, payment details or a complete archive in a first message. Once the receiving clinician has seen the summary, they can say which documents they need and in what form. Translated summaries help, but original laboratory reports should accompany them, because key values and reference ranges can be lost in translation.

Ask the hospital directly whether it wants paper copies, scanned files or both, whether it will accept records in your language, and whether it needs the original pathology material. These are administrative questions whose answers vary by institution, so treat any general statement as a question to confirm rather than a rule. Also ask what the review can and cannot establish: a records-based opinion can comment on classification and options, but it does not replace an examination and does not guarantee acceptance for treatment or eligibility for any trial.

If travel to China is being considered, the timing and duration of any visit, the appointments needed and the cost scope should be confirmed in writing by the providers involved. Our team can help organise records and coordinate appointments, but the clinical assessment and every treatment decision remain with the treating haematologist. An initial enquiry is free and does not commit you to a proxy consultation or any paid service.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. payment
  2. Related treatment reference
  3. Myeloproliferative Neoplasms Treatment - NCI

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.